508 related articles for article (PubMed ID: 29362512)
1. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial.
Schacht JP; Voronin KE; Randall PK; Anton RF
Neuropsychopharmacology; 2018 May; 43(6):1247-1256. PubMed ID: 29362512
[TBL] [Abstract][Full Text] [Related]
2. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
[TBL] [Abstract][Full Text] [Related]
3. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.
Anton RF; Voronin KE; Book SW; Latham PK; Randall PK; Glen WB; Hoffman M; Schacht JP
Alcohol Clin Exp Res; 2020 Oct; 44(10):2084-2096. PubMed ID: 32772383
[TBL] [Abstract][Full Text] [Related]
4. Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone.
Schacht JP; Yeongbin Im ; Hoffman M; Voronin KE; Book SW; Anton RF
Neuropsychopharmacology; 2022 Oct; 47(11):1953-1960. PubMed ID: 35523943
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
Anton RF; Voronin KK; Randall PK; Myrick H; Tiffany A
Alcohol Clin Exp Res; 2012 Nov; 36(11):2000-7. PubMed ID: 22551036
[TBL] [Abstract][Full Text] [Related]
6. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
7. Genetic moderators of naltrexone's effects on alcohol cue reactivity.
McGeary JE; Monti PM; Rohsenow DJ; Tidey J; Swift R; Miranda R
Alcohol Clin Exp Res; 2006 Aug; 30(8):1288-96. PubMed ID: 16899031
[TBL] [Abstract][Full Text] [Related]
8. The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms.
Schacht JP; Anton RF; McNamara PJ; Im Y; King AC
Addict Biol; 2019 Sep; 24(5):1109-1118. PubMed ID: 30230123
[TBL] [Abstract][Full Text] [Related]
9. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
10. Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features.
Gervasini G; Gordillo I; García-Herráiz A; Flores I; Jiménez M; Monge M; Carrillo JA
J Clin Psychopharmacol; 2013 Aug; 33(4):551-5. PubMed ID: 23775054
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity.
Forbes EE; Brown SM; Kimak M; Ferrell RE; Manuck SB; Hariri AR
Mol Psychiatry; 2009 Jan; 14(1):60-70. PubMed ID: 17893706
[TBL] [Abstract][Full Text] [Related]
12. Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity.
Colzato LS; van den Wildenberg WP; Van der Does AJ; Hommel B
Neuroscience; 2010 Oct; 170(3):782-8. PubMed ID: 20678555
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control.
Anton RF; Schacht JP; Voronin KE; Randall PK
Alcohol Clin Exp Res; 2017 Jul; 41(7):1370-1380. PubMed ID: 28493623
[TBL] [Abstract][Full Text] [Related]
14. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
Samochowiec J; Kucharska-Mazur J; Grzywacz A; Jabłoński M; Rommelspacher H; Samochowiec A; Sznabowicz M; Horodnicki J; Sagan L; Pełka-Wysiecka J
Neurosci Lett; 2006 Dec; 410(1):1-5. PubMed ID: 17079080
[TBL] [Abstract][Full Text] [Related]
15. The DRD4 VNTR polymorphism moderates craving after alcohol consumption.
Hutchison KE; McGeary J; Smolen A; Bryan A; Swift RM
Health Psychol; 2002 Mar; 21(2):139-46. PubMed ID: 11950104
[TBL] [Abstract][Full Text] [Related]
16. Parsing out the role of dopamine D4 receptor gene (DRD4) on alcohol-related phenotypes: A meta-analysis and systematic review.
Daurio AM; Deschaine SL; Modabbernia A; Leggio L
Addict Biol; 2020 May; 25(3):e12770. PubMed ID: 31149768
[TBL] [Abstract][Full Text] [Related]
17. Variation in dopamine genes influences responsivity of the human reward system.
Dreher JC; Kohn P; Kolachana B; Weinberger DR; Berman KF
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):617-22. PubMed ID: 19104049
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
Schacht JP; Randall PK; Latham PK; Voronin KE; Book SW; Myrick H; Anton RF
Neuropsychopharmacology; 2017 Dec; 42(13):2640-2653. PubMed ID: 28409564
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the dopamine D4 receptor gene (DRD4 VNTR) and cannabinoid CB1 receptor gene (CNR1) are not strongly related to cue-reactivity after alcohol exposure.
van den Wildenberg E; Janssen RG; Hutchison KE; van Breukelen GJ; Wiers RW
Addict Biol; 2007 Jun; 12(2):210-20. PubMed ID: 17508995
[TBL] [Abstract][Full Text] [Related]
20. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
Psychopharmacology (Berl); 2014 Sep; 231(18):3799-807. PubMed ID: 24647921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
